drugset / Trial / NCT06889012

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers

NCT06889012 ↗

Phase 1 Completed 60 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this clinical study is to evaluate the pharmacokinetics and the safety after administration of BR1018 and coadministration of BR1018A and BR1018B in healthy volunteers

Timeline

Start
2025-05-07
Primary completion
2025-07-23
Completion
2025-07-23

Drugs

EvaluationDrugModalityDoseRoute
Subject BR1018 Unknown — —
Comparator BR1018A Unknown — —
Comparator BR1018B Unknown — —